Surgical Innovations Group plc

("Surgical Innovations", the "Company", or the "Group")

Withdrawal of AGM Resolutions 9 and 10

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), advises that the Board has withdrawn Resolutions 9 and 10 from the agenda of the Annual General Meeting ("AGM") of the Company's shareholders scheduled to be held at 11:00 a.m. tomorrow, 27 June 2025, at the offices of Singer Capital Markets at 1 Bartholomew Lane, London, EC2N 2AX.

Resolutions 9 and 10 were special resolutions relating to the disapplication of pre-emption rights in respect of the allotment of equity securities for cash with limits in line with the Pre-Emption Group's 2022 Statement of Principles.  Whilst the Board considers the flexibility afforded by these authorities to be in the best interests of the Company, it has taken the decision to withdraw Resolutions 9 and 10 from the agenda of the AGM following feedback received from a small number of significant shareholders in the Company since the publication of the notice of the AGM.

The withdrawal of Resolutions 9 and 10 does not affect the validity of the notice of the AGM, the proxy form or any votes submitted in respect of the remaining resolutions to be proposed at the AGM.  Arrangements for the AGM are unchanged from those previously notified as is the numbering of all other proposed resolutions at the AGM.

The withdrawal of Resolutions 9 and 10 does not affect the strategy or the day-to-day running of the business and the Directors do not currently envisage that the business would need to raise new funds through the issue of new shares on a non pre-emptive basis before the 2026 AGM. Should such need arise, a separate General Meeting would be convened to seek shareholder approval at the relevant time.

For further information please contact:

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs, the Company's Reposable portfolio enables healthcare providers to reduce both plastic waste and their CO2 footprint as they strive for net zero.

Further information

Further details of the Group's businesses and products are available on the following websites:

www.sigroupplc.com

www.surginno.com

www.elementalhealthcare.co.uk

To receive regular updates by email, please contact si@walbrookpr.com